{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T12:38:57Z","timestamp":1699965537574},"reference-count":34,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":4239,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1093\/annonc\/mdm596","type":"journal-article","created":{"date-parts":[[2008,1,21]],"date-time":"2008-01-21T20:44:14Z","timestamp":1200948254000},"page":"951-957","source":"Crossref","is-referenced-by-count":2,"title":["Late computed tomography scan response improvement and gallium scintigraphy evaluation as on-treatment prognostic parameters to tailor treatment intensity in patients with Hodgkin's lymphoma. A prospective phase II study"],"prefix":"10.1016","volume":"19","author":[{"given":"A.","family":"Re","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Frata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Pizzocaro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Tucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Facchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.M.","family":"Magrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdm596_bb0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1470-2045(03)01320-2","article-title":"Hodgkin's lymphoma-diagnosis and treatment","volume":"5","author":"Diehl","year":"2004","journal-title":"Lancet Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0015","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2003.07.131","article-title":"Long-term cause-specific mortality of patients treated for Hodgkin's disease","volume":"21","author":"Aleman","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0020","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1200\/JCO.2002.09.038","article-title":"Second malignant neoplasms among long-term survivors of Hodgkin's disease: a population-based evaluation over 25 years","volume":"20","author":"Dores","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0360-3016(94)90222-4","article-title":"Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution","volume":"29","author":"Biti","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1093\/annonc\/mdm596_bb0030","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1182\/blood.V93.3.761","article-title":"Problems in Hodgkin's disease management","volume":"93","author":"Aisenberg","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm596_bb0035","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/oxfordjournals.annonc.a058517","article-title":"Patterns of survival in patients with Hodgkin's disease: long follow-up in a single centre","volume":"4","author":"Oza","year":"1994","journal-title":"Ann Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdm596_bb0040","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1007\/s00259-003-1162-9","article-title":"Assessment of response to therapy using conventional imaging","volume":"30","author":"Rankin","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1093\/annonc\/mdm596_bb0045","series-title":"Hodgkin's Disease","first-page":"223","article-title":"Clinical evaluation and staging","author":"Gupta","year":"1999"},{"key":"10.1093\/annonc\/mdm596_bb0050","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1200\/JCO.1988.6.6.931","article-title":"Residual mass in lymphoma may not be residual disease","volume":"6","author":"Canellos","year":"1988","journal-title":"J Clin Oncol"},{"issue":"Suppl 2","key":"10.1093\/annonc\/mdm596_bb0055","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1093\/annonc\/5.suppl_2.S59","article-title":"The gallium scan predicts relapse in patients with Hodgkin's disease treated with combined modality therapy","volume":"5","author":"Hagemeister","year":"1994","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0060","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1007\/s002590100593","article-title":"Hodgkin's disease: prognostic role of gallium scintigraphy after chemotherapy","volume":"28","author":"Brenot-Rossi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1093\/annonc\/mdm596_bb0065","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1200\/JCO.1997.15.2.518","article-title":"Gallium scans in the management of patients with Hodgkin's disease: a study of 101 patients","volume":"15","author":"Salloum","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0070","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/1097-0142(20010115)91:2<302::AID-CNCR1002>3.0.CO;2-4","article-title":"Whole body positron emission tomography in the treatment of Hodgkin disease","volume":"91","author":"Hueltenschmidt","year":"2001","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdm596_bb0075","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1200\/JCO.1993.11.6.1092","article-title":"Gallium scans in patients with mediastinal Hodgkin's disease treated with chemotherapy","volume":"11","author":"Cooper","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0080","doi-asserted-by":"crossref","first-page":"56","DOI":"10.3816\/CLM.2004.n.011","article-title":"The use of gallium-67 scintigraphy to monitor tumor response rates and predict long-term clinical outcome in patients with lymphoma","volume":"5","author":"Tuli","year":"2004","journal-title":"Clin Lymphoma"},{"key":"10.1093\/annonc\/mdm596_bb0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/radiology.210.2.r99fe07487","article-title":"Hodgkin disease: prediction of outcome with 67Ga scintigraphy after one cycle of chemotherapy","volume":"210","author":"Front","year":"1999","journal-title":"Radiology"},{"key":"10.1093\/annonc\/mdm596_bb0090","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1093\/annonc\/mdi200","article-title":"Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma","volume":"16","author":"Hutchings","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1182\/blood-2005-06-2252","article-title":"FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma","volume":"107","author":"Hutchings","year":"2006","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm596_bb0100","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of Haematopoietic and Lymphoid Tissues","first-page":"237","article-title":"Hodgkin lymphoma","author":"Stein","year":"2001"},{"key":"10.1093\/annonc\/mdm596_bb0105","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1056\/NEJM199811193392104","article-title":"A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease","volume":"21","author":"Hasenclever","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1093\/annonc\/mdm596_bb0110","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0115","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1200\/JCO.2005.01.904","article-title":"Role of positron emission tomography in lymphoma","volume":"23","author":"Jeweid","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0120","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0002-9343(01)01117-2","article-title":"Fluorine-18 fluorodeoxyglucose positron emission tomography, gallium-67 scintigraphy, and conventional staging for Hodgkin's disease and non-Hodgkin's lymphoma","volume":"112","author":"Wirth","year":"2002","journal-title":"Am J Med"},{"key":"10.1093\/annonc\/mdm596_bb0125","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/1042819031000149430","article-title":"FDG-PET is superior to gallium scintigraphy in staging and more sensitive in the follow-up of patients with de novo Hodgkin lymphoma: a blinded comparison","volume":"45","author":"Friedberg","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdm596_bb0130","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2005.09.085","article-title":"Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group","volume":"23","author":"Meyer","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0135","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/blood-2004-04-1311","article-title":"Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed be radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease","volume":"104","author":"Straus","year":"2004","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdm596_bb0140","doi-asserted-by":"crossref","first-page":"561S","DOI":"10.1200\/jco.2005.23.16_suppl.6505","article-title":"First results of the EORTC-GELA H9 randomized trials: the H9-F trial (comparing 3 radiation dose levels) and H9-U trial (comparing 3 chemotherapy schemes) in patients with favourable or unfavourable early stage Hodgkin lymphoma","volume":"23","author":"Noordijk","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0145","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1200\/JCO.2003.03.023","volume":"21","author":"Engert","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0150","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0167-8140(88)90247-2","article-title":"Thoracic CT-scanning follow-up of residual mediastinal masses after treatment of Hodgkin's disease","volume":"11","author":"Thomas","year":"1988","journal-title":"Radiother Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0155","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1056\/NEJMoa022628","article-title":"Involved-field radiotherapy for advanced Hodgkin's lymphoma","volume":"348","author":"Aleman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm596_bb0160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1200\/JCO.2004.01.021","article-title":"Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need?","volume":"22","author":"Laskar","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0165","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1200\/JCO.1998.16.3.818","article-title":"Meta-analysis of chemotherapy versus combined modality treatment trials in Hodgkin's disease","volume":"16","author":"Loeffler","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdm596_bb0170","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1056\/NEJMoa022473","article-title":"Standard and increased-dose BEACOPP chemotherapy compared with COPP-ABVD for advanced Hodgkin's disease","volume":"348","author":"Diehl","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdm596_bb0175","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson","year":"2007","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419418516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419418516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/19\/5\/951\/401590\/mdm596.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T08:34:48Z","timestamp":1582187688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419418516"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":34,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["S0923753419418516"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdm596","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}